Albemarle Corporation

ALB

US0126531013

Specialty Chemicals

Real-time Estimate Cboe BZX Other stock markets 01:08:36 2026-02-18 pm EST			5-day change	1st Jan Change
174.28 ^USD	+3.18%		-0.95%	+22.85%

08:46am	Evercore ISI Adjusts Price Target on Albemarle to $180 From $100, Maintains In Line Rating	MT
Feb. 17	Evercore ISI Raises Albemarle Price Target to $180 From $100	MT

Albemarle Corporation Announces Executive Changes

Published on 08/12/2025 at 04:33 pm EDT

S&P Capital IQ

ALBEMARLE CORPORATION

+3.18%

Albemarle Corporation announced changes to its organizational structure that resulted in Netha N. Johnson, Chief Operations Officer, leaving the Company effective August 10, 2025. Mark M. Mummert, age 57, will succeed Mr. Johnson as Chief Operations Officer. Mr. Mummert has served as Senior Vice President and Chief Capital, Resources and Integrated Supply Chain Officer since November 2024.

Since joining the Company in 2019, he served as Chief Operating Officer for the Energy Storage business until May 2024 when he was appointed as Senior Vice President, Capital Projects and Integrated Supply Chain. Before joining the Company, Mr. Mummert held progressive leadership roles in supply chain and global operations at FMC Corporation. His industry experience also includes 20 years with Rohm and Haas Company in various manufacturing and engineering roles.

Additionally, Mr. Mummert previously served in roles with The Dow Chemical Company.

Latest news about Albemarle Corporation

08:46am	Evercore ISI Adjusts Price Target on Albemarle to $180 From $100, Maintains In Line Rating	MT
Feb. 17	Evercore ISI Raises Albemarle Price Target to $180 From $100	MT
Feb. 17	BofA Upgrades Albemarle to Buy From Neutral as 'Pricing Structurally Improves', Raises Price Target to $190 From $167	MT
Feb. 17	Albemarle Has Executed Through Downturn, Now Positioning For Recovery, BofA Says	MT
Feb. 17	RBC Adjusts Price Target on Albemarle to $216 From $200, Maintains Outperform Rating	MT
Feb. 17	BofA Upgrades Albemarle to Buy From Neutral, Price Target is $190	MT
Feb. 17	Deutsche Bank Adjusts Albemarle Price Target to $195 From $185, Maintains Buy Rating	MT
Feb. 13	JPMorgan Adjusts Price Target on Albemarle to $145 From $195, Maintains Neutral Rating	MT
Feb. 13	Citigroup Adjusts Price Target on Albemarle to $190 From $180, Maintains Neutral Rating	MT
Feb. 13	Morgan Stanley Raises Price Target on Albemarle to $170 From $147, Keeps Equalweight Rating	MT
Feb. 12	Chile lithium revenue comes in under half projected amount in 2025, newspaper reports	RE
Feb. 12	Albemarle CEO: Acquisitions 'not really our focus at this point in the cycle'	RE
Feb. 12	Mizuho Adjusts Price Target on Albemarle to $185 From $156, Maintains Neutral Rating	MT
Feb. 12	Albemarle Corporation, Q4 2025 Earnings Call, Feb 12, 2026
Feb. 11	Albemarle to idle Australia lithium plant after profit miss	RE

Chart Albemarle Corporation

Duration

Period

ALB: Dynamic Chart

Company Profile

Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows: - lithium and polymer solutions (52.7%); - bromine (26.6%); - catalysts (20.7%). Net sales are distributed geographically as follows: the United States (17.3%), China (39.4%), South Korea (15.4%), Japan (7%) and other (20.9%).

Employees

7,800

Sector

Specialty Chemicals

Calendar

May. 05 - Q1 2026 Earnings Release (Projected)

More about the company